Next-Generation Antiviral Therapeutics: Platforms Beyond Small Molecules and Monoclonal Antibodies
The landscape of antiviral therapy is rapidly evolving. While small molecules and monoclonal antibodies have been the mainstays, limitations like viral resistance and the emergence of new pathogens necessitate exploring innovative therapeutic platforms. The goal is to develop strategies that offer b ...